A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.

NCT00532090 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche